Effect of interferon-α on chromosome abnormalities in treated chronic myelogenous leukemia patients

Cancer Genetics and Cytogenetics

Volumn 153, Issue 2, 2004, Pages 133-143

  Tanaka, Hideo ^a   Tanaka, Kimio ^b   Oguma, Nobuo ^c   Ito, Kinro ^a   Ito, Takuo ^a   Kyo, Taiichi ^d   Dohy, Hiroo ^d   Kimura, Akiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b INSTITUTE FOR ENVIRONMENTAL SCIENCES   (Japan)

^c Department of Internal Medicine   (Japan)

^d Fourth Dept of Internal Medicine   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BUSULFAN; HYDROXYUREA; MERCAPTOPURINE; METHOTREXATE; RANIMUSTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ATOMIC BOMB; BLAST CELL CRISIS; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CHILD; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHRONIC MYELOID LEUKEMIA; CHRONICITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GENE FREQUENCY; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN CELL; JAPAN; MAJOR CLINICAL STUDY; MALE; MONOSOMY 7; PRIORITY JOURNAL; RADIATION EXPOSURE; SPLENECTOMY; SURVIVAL TIME; TREATMENT OUTCOME; TRISOMY 8;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BUSULFAN; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; INTERFERON-ALPHA; JAPAN; KARYOTYPING; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WARFARE;

EID: 9944234908     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2004.01.019     Document Type: Article

References (35)

1. H.M. Kantarjian, M.J. Keating, M. Talpaz, R.S. Walters, T.L. Smith, A. Cork, K.B. McCredie, and E.J. Freireich Chronic myelogenous leukemia in blast crisis: analysis of 242 patients Am J Med 83 1987 445 454
2. F. Mitelman The cytogenetic scenario of chronic myeloid leukemia Leuk Lymphoma 11 Suppl 1993 11 15
3. P. Ruff, E. Saragas, M. Poulos, and A. Weaving Patterns of clonal evolution in transformed chronic myelogenous leukemia Cancer Genet Cytogenet 81 1995 182 184
4. F. Mitelman, G. Levan, P.G. Nilsson, and L. Brandt Non-random karyotypic evolution in chronic myeloid leukemia Int J Cancer 18 1976 24 30
5. B. Johansson, T. Fioretos, R. Billström, and F. Mitelman Aberrant cytogenetic evolution pattern of Philadelphia-positive chronic myeloid leukemia treated with interferon-α Leukemia 10 1996 1134 1138
6. Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer [Internet]. Accessed November 1, 2003. Available from http://cgap.nci.nih.gov/Chromosomes/Mitelman.
7. B. Johansson, T. Fioretos, and F. Mitelman Cytogenetic and molecular genetic evolution of chronic myeloid leukemia Acta Haematol 107 2002 76 94
8. G. Alimena, L. Brandt, B. Dallapiccola, F. Mitelman, and P.G. Nilsson Secondary chromosome changes in chronic myeloid leukemia: relation to treatment Cancer Genet Cytogenet 1 1979 79 85
9. E.W. Fleischman, E.L. Prigogina, M.A. Volkova, M.A. Frenkel, N.A. Zakhartchenko, L.N. Konstantinova, G.P. Puchkova, and S.A. Balakirev Correlations between the clinical course, characteristics of blast cells, and karyotype patterns in chronic myeloid leukemia Hum Genet 58 1981 285 293
10. G. Nanjangud, P.R. Kadam, T. Saikia, A.N. Bhisey, A. Kumar, R. Gopal, H. Chopra, C.N. Nair, and S.H. Advani Karyotypic findings as an independent prognostic marker in chronic myelogenous leukaemia blast crisis Leuk Res 18 1994 385 392
11. C. Bilhou-Nabera, P. Bernard, G. Marit, F. Viard, M.J. Gharbi, Z. Wen, F. Lacombe, A. Broustet, and J. Reiffers Serial cytogenetic studies in allografted patients with chronic myeloid leukemia Bone Marrow Transplant 9 1992 263 268
12. A. Chase, J. Pickard, R. Szydlo, S. Coulthard, J.M. Goldman, and N.C.P. Cross Non-random involvement of chromosome 13 in patients with persistent or relapsed disease after bone-marrow transplantation for chronic myeloid leukemia Genes Chromosomes Cancer 27 2000 278 284
13. F. Hild, M. Freund, and C. Fonatsch Chromosomal aberrations during interferon therapy for chronic myelogenous leukemia N Engl J Med 325 1991 132
14. L. Fayad, H. Kantarjian, S. O'Brien, D. Seong, M. Albitar, M. Keating, and M. Talpaz Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases Leukemia 11 1997 767 771
15. F. Maloisel, F. Uettwiller, A. Laplace, B. Lioure, R. Herbrecht, M. Mark, and P. Dufour Emergence of unusual cytogenetic abnormalities under interferon-alpha therapy in patients with chronic myelogenous leukemia Cancer Genet Cytogenet 113 1999 172 176
16. A. Majlis, T.L. Smith, M. Talpaz, S. O'Brien, M.B. Rios, and H.M. Kantarjian Significance of cytogenetic clonal evolution in chronic myelogenous leukemia J Clin Oncol 14 1996 196 203
17. B. Johansson, F. Mertens, and F. Mitelman Geographic heterogeneity of neoplasia-associated chromosome aberrations Genes Chromosomes Cancer 3 1991 1 7
18. M. Hoshi, M. Matsuura, N. Hayakawa, C. Ito, and N. Kamada Estimation of radiation doses for atomic-bomb survivors in the Hiroshima University Registry Health Phys 70 1996 735 740
19. M. Seabright A rapid banding technique for human chromosomes Lancet 2 7731 1971 971 972
20. F. Mitelman An international system for human cytogenetic nomenclature 1995 S. Karger Basel
21. E. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
22. B. Swolin, A. Weinfeld, J. Westin, J. Waldenström, and B. Magnusson Karyotypic evolution in Ph-positive chronic myeloid leukemia in relation to management and disease progression Cancer Genet Cytogenet 18 1985 65 79
23. S. Imashuku, S. Hibi, Y. Kataoka-Morimoto, T. Yoshihara, S. Ikushima, Y. Morioka, and S. Todo Myelodysplasia and acute myeloid leukaemia in case of aplastic anaemia and congenital neutropenia following G-CSF administration Br J Haematol 89 1995 188 190
24. K. Kaito, M. Kobayashi, T. Katayama, H. Masuoka, T. Shimada, K. Nishiwaki, T. Sekita, H. Otsubo, Y. Ogasawara, and T. Hosoya Long-term administration of G-CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 Br J Haematol 103 1998 297 303
25. G.R. Stark, I.M. Kerr, B.R.G. Williams, R.H. Silverman, and R.D. Schreiber How cells respond to interferons Annu Rev Biochem 67 1998 227 264
26. A.J. Whiteway, C.D.L. Reid, and N.C.P. Cross An extremely delayed cytogenetic response to interferon-α in a patient with chronic myeloid leukaemia Leukemia 11 1997 614 616
27. The Italian Cooperative Study Group on Chronic Myeloid Leukemia Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia N Engl J Med 330 1994 820 825
28. Chronic Myeloid Leukemia Trialists' Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials J Natl Cancer Inst 89 1997 1616 1620
29. X.Q. Ge, K. Tanaka, A. Mansyur, H. Tazawa, K. Iwato, T. Kyo, H. Dohy, and N. Kamada Possible prediction of myeloid and lymphoid crises in chronic myelocytic leukemia at onset by determining the methylation status of the major breakpoint cluster region Cancer Genet Cytogenet 126 2001 102 110
30. N. Kamada, and K. Tanaka Cytogenetic studies of hematological disorders in atomic bomb survivors T. Ishihara M.S. Sasaki Radiation-induced chromosome damage in man 1983 Alan R. Liss New York 455 474
31. K. Tanaka, M. Takechi, J. Hong, C. Shigeta, N. Oguma, N. Kamada, Y. Takimoto, A. Kuramoto, H. Dohy, and T. Kyo 9;22 translocation and bcr rearrangements in chronic myelocytic leukemia patients among atomic bomb survivors J Radiat Res 30 1989 352 358
32. K. Tanaka, T. Hashimoto, N. Oguma, H. Dohy, and N. Kamada Influence of M-BCR breakpoint sites on the duration of chronic phase in 100 patients with chronic myelocytic leukemia Cancer Genet Cytogenet 70 1993 39 47
33. P. Meeus, H. Demuynck, P. Martiat, L. Michaux, E. Wouters, and A. Hagemeijer Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with imatinib Leukemia 17 2003 465 467
34. M.K. Andersen, J. Pedersen-Bjergaard, L. Kjeldsen, I.H. Dufva, and K. Brøndum-Nielsen Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8 Leukemia 16 2002 1390 1393
35. C. Schoch, T. Haferlach, W. Kern, S. Schnittger, U. Berger, R. Hehlmann, W. Hiddemann, and A. Hochhaus Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate Leukemia 17 2003 461 463